'Open access' announcement scuttled

NIH cancels teleconference with Zerhouni, reportedly over fears of political controversy

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The National Institutes of Health (NIH) abruptly cancelled a teleconference with director Elias A. Zerhouni scheduled for Tuesday (January 11), at which he was to announce "a new policy designed to accelerate the public's access to published articles resulting from NIH-funded research."

Zerhouni had planned to unveil the final version of the agency's long-awaited and controversial policy regarding publication of NIH-sponsored research results. The agency's draft version, issued September 3, 2004, requested that electronic copies of all final manuscripts based on NIH-sponsored research be made available through NIH's PubMed Central database 6 months after being accepted for journal publication.

It was anticipated that the final policy would have extended the time frame to 12 months, several sources said yesterday. The change was intended to be a compromise with scientific journal publishers and nonprofit research societies that had argued that open access would negatively affect their businesses or abilities to continue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo